中文 | English
Return
Total: 912 , 1/92
Show Home Prev Next End page: GO
Author:(Hai-hong LIU)

2.Lead compound optimization strategy (2)--structure optimization strategy for reducing toxicity risks in drug design.

Hai-Long LIU ; Jiang WANG ; Dai-Zong LIN ; Hong LIU

Acta Pharmaceutica Sinica 2014;49(1):1-15

7.Protective effects and mechanism of dihydromyricetin on non-alcoholic fatty liver disease in ApoE-/-mice

hong Hai LIU

Chinese Traditional Patent Medicine 2017;39(12):2448-2453

8.Investigation of Microcystin-LR Pollution in Large Reservoirs in Taiyuan

Zhi-Hong ZHANG ; Guo-Guo QIAO ; Hai-Fang LIU ;

Journal of Environment and Health 2007;0(08):-

9.Survey Analysis on Blood Lead Level of Children in Jinchang City of Gansu Province

yi-pa, SAI ; zheng-hong, LIU ; hai-jin, XIONG

Journal of Applied Clinical Pediatrics 1986;0(02):-

10.Clinical and Radiographic Features of Short Stature Combined with Skeletal Deformity in Children

hai-yan, LI ; hong-wei, MA ; wei-liang, LIU

Journal of Applied Clinical Pediatrics 2006;0(20):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 912 , 1/92 Show Home Prev Next End page: GO